Search results
uniQure (QURE) Partner Gets FDA Nod for Hemophilia B Gene Therapy
Zacks via Yahoo Finance· 1 year agoShares of uniQure QURE were up 7.08% during market hours after the company announced that its...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 17 hours agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
CSL Ltd's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 months agoCSL Ltd (CSLLY) recently announced a dividend of $0.6 per share, payable on a date yet to be announced, with the ex-dividend date set for 2024-03-11. As...
The most expensive drug in the world has a $3.5 million price tag. 2 potential patients share their...
Business Insider via Yahoo News· 1 year agoBryen Lackey, 18, has the genetic bleeding disorder hemophilia B. He said he could be interested in...
Australia's CSL prices hemophilia gene therapy at $3.5 million
Reuters via Yahoo News· 1 year ago(Reuters) -Australian drugmaker CSL Ltd on Tuesday set the list price of its one-time gene therapy...
uniQure (QURE) Up on Restructuring Plans, Workforce Reduction
Zacks via Yahoo Finance· 7 months agoShares of uniQure N.V. QURE were up 11.61% on Oct 5 after the company announced a strategic...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 3 weeks agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback
Zacks via Yahoo Finance· 7 months agoIt was a busy week for the biotech sector. M&A is back in the spotlight in the sector as Bristol...
FDA Accepts Pfizer's (PFE) Hemophilia B Gene Therapy Filing
Zacks via Yahoo Finance· 11 months agoPfizer PFE announced that its regulatory submissions in the United States and European Union (“EU”)...
Why Shares of uniQure Are Dropping Tuesday
Motley Fool· 8 months agoShares of uniQure (NASDAQ: QURE) were down more than 11% as of 1:06 p.m. on Tuesday after the gene-therapy company announced that the Food and Drug...
